MHRA Alert: Hormone replacement therapy (HRT) and increased risk of breast cancer

MHRA Alert: Hormone replacement therapy (HRT) and increased risk of breast cancer

August 30, 2019

An important new study has confirmed and extended knowledge on the risk of breast cancer with use of systemic Hormone Replacement Therapy (HRT) oral or applied under or to the skin such as gels or patches (transdermal).

The risk of breast cancer falls after stopping HRT, but the new analysis shows some excess risk of breast cancer persists for more than 10 years after stopping HRT. This means the total number of additional HRT-related cases diagnosed in the period after stopping HRT up to age 69 years is higher than previously thought.

Click here for further information.



Posted in:


More Latest News >

CPCS webinar now on-demand

Community pharmacy contractors can now access an online recording of our webinar about the new NHS Community Pharmacist Consultation Service...